Modern treatment of ankylosing spondylitis

被引:2
|
作者
Rehart, S.
Kerschbaumer, F.
Braun, J.
Sieper, J.
机构
[1] Akad Lehrkrankenhaus, Markus KH, Klin Orthopad & Unfallchirurg, D-60431 Frankfurt, Germany
[2] Klin Rotes Kreuz, Frankfurt, Germany
[3] St Josefkrankenhaus, Rheumazentrum Ruhrgebiet, Herne, Germany
[4] Univ Med Berlin, Charite, Med Klin 1, Berlin, Germany
来源
ORTHOPADE | 2007年 / 36卷 / 10期
关键词
spondylarthritis ankylopoetica; inflammatory back pain; TNF alpha inhibitor; spondylodesis; synovectomy;
D O I
10.1007/s00132-007-1154-8
中图分类号
R826.8 [整形外科学]; R782.2 [口腔颌面部整形外科学]; R726.2 [小儿整形外科学]; R62 [整形外科学(修复外科学)];
学科分类号
摘要
Bechterew's disease belongs to subgroup of spondyloarthritis. Even today there is still a delay of 5-10 years between the first occurrence of symptoms and the final diagnosis of ankylosing spondylitis. Without treatment the spine increasingly stiffens and the peripheral (mostly large) joints are often destroyed by inflammatory processes. Ankyloses of the joints between vertebrae and ribs may cause stiffness of the thorax. As the complaints most often start within the third decade of life and show a chronic progressive course, even young adults often have to deal with a considerable impairment due to pain and stiffness. Thus, early diagnosis is of utmost importance as today treatment with novel drugs is feasible and the TNFα inhibitors are particularly effective during the early stages of the disease. All conservative orthopedic measures are used concomitantly. Surgery encompasses the early resection of inflamed mucosa in joints. In later stages of the disease reconstructive methods, i.e. prosthetics are often applied. Spondylodesis to erect the body, necessary in the end stage of the disease, is beneficial, but elaborate. © 2007 Springer Medizin Verlag.
引用
收藏
页码:963 / 972
页数:10
相关论文
共 50 条
  • [41] Ankylosing spondylitis: New treatment modalities
    Brandt, Jan
    Marzo-Ortega, Helena
    Emery, Paul
    BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY, 2006, 20 (03): : 559 - 570
  • [42] TREATMENT MANAGEMENT IN ANKYLOSING-SPONDYLITIS
    DOURY, P
    MEDECINE ET ARMEES, 1988, 16 (07): : 545 - 549
  • [43] Ankylosing spondylitis - Current approaches to treatment
    Toivanen, A
    Mottonen, T
    BIODRUGS, 1998, 10 (03) : 193 - 200
  • [44] Recommendations for the management and treatment of ankylosing spondylitis
    Sampaio-Barros, Percival Degrava
    Keiserman, Mauro
    Meirelles, Eduardo de Souza
    Pinheiro, Marcelo de Medeiros
    Ximenes, Antonio Carlos
    Azevedo, Valderilio Feijo
    Bonfiglioli, Rubens
    Carneiro, Sueli
    Ranza, Roberto
    Bernardo, Wanderley
    Goncalves, Celio Roberto
    REVISTA BRASILEIRA DE REUMATOLOGIA, 2013, 53 (03) : 242 - 257
  • [45] Is methotrexate effective for the treatment of ankylosing spondylitis?
    Junmin Chen
    Nature Clinical Practice Rheumatology, 2007, 3 : 490 - 491
  • [46] Biologic therapies for the treatment of ankylosing spondylitis
    Ahn, Soo Min
    Kim, Yong-Gil
    JOURNAL OF THE KOREAN MEDICAL ASSOCIATION, 2021, 64 (02): : 116 - 123
  • [47] Treatment of ankylosing spondylitis: focus on etanercept
    Frech, Tracy
    BIOLOGICS-TARGETS & THERAPY, 2007, 1 (01): : 45 - 51
  • [48] The Epidemiology and Treatment of Ankylosing Spondylitis in Korea
    Kwon, Seong-Ryul
    Kim, Tae-Hwan
    Kim, Tae-Jong
    Park, Won
    Shim, Seung Cheol
    JOURNAL OF RHEUMATIC DISEASES, 2022, 29 (04): : 193 - 199
  • [49] Is methotrexate effective for the treatment of ankylosing spondylitis?
    Chen, Junmin
    NATURE CLINICAL PRACTICE RHEUMATOLOGY, 2007, 3 (09): : 490 - 491
  • [50] FENBUFEN IN THE TREATMENT OF ANKYLOSING-SPONDYLITIS
    SIEMENS, P
    PHARMACOLOGY, 1982, 25 : 51 - 53